InCarda at AF Symposium

January 24, 2019 – Boston, MA

At the 2019 AF Symposium held in Boston, MA, Dr. Jeremy Ruskin presented an overview InCarda’s program of inhaled flecainide for treatment of Paroxysmal Atrial Fibrillation to several hundred clinicians in the audience.  Dr. Ruskin is Founder and Director of the Cardiac Arrhythmia Service at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School.   He is also the founder and coordinator of the AF Symposium.  The AF Symposium is the premier medical conference for Electrophysiologists and Cardiologists and focuses on innovative Atrial Fibrillation treatment approaches.